REPL - Replimune Group, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue3/31/20193/31/20183/31/2017
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development19,64511,2495,494
Selling General and Administrative8,7735,7132,711
Non Recurring---
Others---
Total Operating Expenses28,41816,9628,205
Operating Income or Loss-28,418-16,962-8,205
Income from Continuing Operations
Total Other Income/Expenses Net-2,416-2,740501
Earnings Before Interest and Taxes-28,418-16,962-8,205
Interest Expense---
Income Before Tax-30,834-19,702-7,704
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-30,834-19,702-7,704
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-30,834-19,702-7,704
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-30,834-19,702-7,704